Inibio Co.

Healthcare SpecialistsSeries CBucheon, South Koreainibio.com

Latest round

Series C

Last raised

May 2021

Total raised

$17M

Investors

7

About Inibio Co.

, Ltd. operates as a company specializing in protein drug development. In February 2022, Inibio Inc. The company possesses protein drug platform technology and Botulinum toxin (aka Botox) injection that is undergoing a clinical trial for glabellar wrinkles and is expected to be released after completing domestic clinical trials. Its pipeline products include cosmeceuticals, medical devices, biopharmaceuticals, natural products, and cosmetics As of 2022, Inibio Inc. has obtained approval for pharmaceutical manufacturing and quality control and export licenses allowing the company to reach the global markets of the US, Europe, China, and Brazil. Inibio plans to complete the selection of a listing manager and be listed on the KOSDAQ within 2022.

Who invested in Inibio Co.

7 investors across 2 rounds

See all investors in Inibio Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    May 1, 2021

    Amount

    $11M

    Investors

    Locked

  2. Series B

    Jun 1, 2019

    Amount

    $5.3M

    Investors

    Locked

Questions about Inibio Co.

Who invested in Inibio Co.?

Inibio Co. has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Inibio Co. raised?

Inibio Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Inibio Co. last raise money?

Inibio Co.'s most recent round on record is a Series C, in May 2021.

What does Inibio Co. do?

Inibio Co. is a healthcare specialists company.

Where is Inibio Co. headquartered?

Inibio Co. is headquartered in Bucheon, South Korea.

Which VCs invest in companies like Inibio Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare specialists companies at Inibio Co.'s stage. Their profiles are linked below.

Raising like Inibio Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.